ArticleNature medicine2024

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

Andrea J Bullock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.